CD47 and breast carcinoma: CD47 antibody treatment or CD47 knockdown suppressed stem cell character in hepatocarcinoma, MDA-MB-231 breast carcinoma, and glioma cells (Lee et al., 2014; Soto-Pantoja et al., 2015; Li et al., 2018; Tan et al., 2019).